Company Filing History:
Years Active: 2017-2019
Title: Alexander Plotnikov: Innovator in Peptide Research
Introduction
Alexander Plotnikov is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of peptide research, particularly in the development of ERK-derived peptides. With a total of two patents to his name, Plotnikov's work has implications for understanding cellular signaling pathways.
Latest Patents
Among his latest patents is the invention of ERK-derived peptides and their uses. This patent describes an isolated peptide that is no longer than 20 amino acids, comprising a sequence that is at least 95% homologous to the sequence GQLNHILGILGXPXQED (SEQ ID NO: 4). The peptide is capable of preventing extracellular signal-regulated kinase 1/2 (ERK) translocation into the nucleus. This innovation has the potential to impact therapeutic strategies targeting cellular signaling.
Career Highlights
Alexander Plotnikov is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in peptide technology. His work is characterized by a focus on the molecular mechanisms of cell signaling, which is crucial for developing new therapeutic approaches.
Collaborations
Some of his notable coworkers include Rony Seger, who has collaborated with Plotnikov on various research projects. Their joint efforts have contributed to the advancement of knowledge in the field of cellular signaling.
Conclusion
In summary, Alexander Plotnikov is a prominent inventor whose work in peptide research has led to significant advancements in understanding cellular mechanisms. His contributions are paving the way for future innovations in therapeutic applications.